Abstract: Disclosed are a production logging tool and method for evaluating fluid produced from a formation of an oilfield. The fluid is measured by a water sensor to determine if the fluid is water, and a chloride sensor to determine chloride levels of the fluid. Based on the chloride levels of the fluid, it can be determined whether the fluid is naturally occurring water, or if the fluid is an injection fluid.

Abstract: A device for measuring the spring rate of a golf ball is disclosed. The device receives a golf ball between a first anvil and a second anvil. A force gauge is provided on one anvil. A displacer is provided on another anvil. Each anvil defines a ball receiving depression that is larger than the dimples of the golf ball to be measured for negating measurement effects due to golf ball dimples when measurement of the golf ball is conducted. The displacement an anvil is determined. From the force data and displacement data, a spring rate of the golf ball can be calculated and a compression scale value may be calculate and displayed on the device for informing a golfer that is operating the hand held device.

Abstract: A process for determining a root cause problem for an out-of-tolerance component manufactured by a plurality of operations performed on the component. The process can include providing manufacturing data from at least a subset of plurality of operations performed on a plurality of components and discovering an out-of-tolerance measurement on at least a subset of the plurality of manufactured components downstream from the plurality of operations. An auto-regression analysis between the out-of-tolerance measurement and the plurality of upstream operations can also be performed using the manufacturing data. A correlation between at least one of the upstream operations and the out-of-tolerance measurement can be found and the correlation can result in the identification of at least one upstream operation that is the root cause of the out-of-tolerance measurement.

Abstract: The present invention is directed to a novel enteric-coated oral dosage form of a risedronate active ingredient comprised of a safe and effective amount of a pharmaceutical compostion which is comprised of a risedronate active ingredient and pharmaceutically-acceptable excipients. Said dosage forms prohibit the exposure of the risedronate active ingredient to the epithelial and mucosal tissues of the buccal cavity, pharynx, esophagus, and stomach and thereby protects said tissues from erosion, ulceration or other like irritation. Accordingly, the said dosage forms effect the delivery to the lower intestinal tract of said human or other mammal of a safe and effective amount of the risedronate active ingredient, and substantially alleviate the esophagitis or esophageal irritation which sometimes accompanies the oral administration of risedronate active ingredients.

Abstract: The invention relates to a ready-to-use binary gaseous mixture containing 63.1 to 69.9% by volume of helium and the remainder being oxygen, preferably a mixture of 65% of helium and of 35% of oxygen, and its use in the treatment of asthma, of obstructive bronchopneumopathies and the like. Such a gaseous mixture can be used as a vector or propellant gas for medicinal aerosols, in particular aerosols containing a therapeutically effective substance chosen from &bgr;2-mimetics, corticoids and anticholinergics.

Abstract: The present invention provides a gastric and/or duodenal adhesive pharmaceutical composition obtained by coating a composition, which comprises a medicament acting at the stomach and/or duodenum and one or more of ingredients selected from water insoluble polymers, polyglycerin fatty acid esters, lipids and waxes, with a polymer having adhesive capacity onto the surface of the mucosa of a digestive tract under acid conditions and separates from the mucosa of the digestive tract in neutral or alkaline conditions. This composition adheres only to the mucosa of the stomach and/or duodenum and releases the medicament over long hours so that sufficient effects are available by a small amount of the medicament.

Abstract: A natural, organic, curative, skin restructuring cosmetic complex for a composition according to the present invention provides very effective retexturization of the skin, producing significantly improved smoothness, as well as significantly increasing the firmness and moisture content of the skin and regulating wrinkles in and/or degeneration of human skin, together with improving overall tone of the skin and decreasing the level of free radicals in the skin. The restructuring composition comprises safe and effective amounts of carrageenans, borage seed oil, squalane, ceramide 3, ceramide 6, red algae extract, dipalmitoyl hydroxyproline and oleuropein, while maintaining their optimum stability.

Abstract: This invention provides compositions and methods useful for repelling target pests. The compositions comprise an amount of a monoterpenoid or sesquiterpenoid effective to repel a target pest from a target area, the monoterpenoid or sesquiterpenoid in combination with a carrier. In one embodiment, the monoterpenoid or sesquiterpenoid is from a biorational source, such as a plant volatile. In a particular embodiment, the plant volatile is a monoterpenoid, such as “nepetalactone” (or the individual nepetalactone isomers) derived from catnip (Nepeta cataria). In another embodiment, the plant volatile is any one or a combination of sesquiterpenoids derived from the fruit of the Osage orange tree (Maclura pomifera). Such compositions have repellency against arthropods, such as cockroaches, mosquitoes, mites, ticks, spiders, and so forth.

Abstract: Low-viscosity cosmetic or dermatological preparations of the oil-in-water type, which comprise an oil phase, in which hydrophobic and/or amphiphilic solids are incorporated, and a water phase, where the difference in density between the oil phase and the water phase (determinable using a computerized digital density meter of the type DMA 45 from chempro/PA at 25° C.) is not greater than 0.01 g·cm−3, and method of stabilizing O/W formulations.

Abstract: This invention provides a feedstock for improving the lactational performance of dairy cows. An essential feature of the feedstock is a dietary cation-anion difference (DCAD) with a value between about 20-60 meq/100 g dietary DM. Other essential features of the feedstock are an atomic ratio of potassium:sodium between about 1-5:1, and a weight ratio of potassium:magnesium between about 3-5:1.

Abstract: Acetyldinaline in combination with gemcitabine, a pharmaceutically acceptable salt thereof, capecitabine, or cisplatin is synergistic for treating cancer.

Abstract: Provided herein is a novel and useful device and method for locally delivering and controllably releasing oxybutynin in the cervical region of a female. A device of the invention comprises a ring comprising trifluoropropylmethyl/dimethyl siloxane elastomer. A pharmaceutical composition comprising oxybutynin and an excipient is placed within a bore located in the ring, wherein the bore runs from the surface of the ring into the ring. The ring has a sufficient size such that it can be inserted into the vaginal canal of a female. A cap comprising is placed over the bore at the surface of the ring in order to contain the pharmaceutical composition within the bore. When the ring is inserted into the vaginal canal, the trifluoropropylmethyl/dimethyl siloxane elastomer controllably releases and locally delivers a therapeutically effective amount of oxybutynin to the detrusor muscle to treat the female's urinary incontinence.

Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.

Abstract: A method of making an herbal drink for relieving symptoms of fatigue, congestion, fever and asthma. The method of making an herbal drink includes making an herbal drink for relieving symptoms of various ailments such as cough, fever and fatigue. The drink is formed by straining water through a combination of equal portions of rosehip, goldenseal, comfrey leaf, bee pollen, spearmint, chickweed, comfrey root, chamomile flower, catnip, mullein, pennyroyal, eucalyptus, and licorice root.